HOLLAND & KNIGHT LLP

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biopharmaceutical Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $20,000.00 income · posted Jan 13, 2026

Lobbying activity 1

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem